Legal News - Momenta, Novartis, Sanofi fall on Lovenox suit
Legal News Home page Click here to add this website to your favorites
  rss
Bar News Search >>>

Shares of partners Momenta Pharmaceuticals and Novartis AG moved notably lower early Tuesday, the day after rival Sanofi-Aventis filed a federal lawsuit to prevent the companies from launching a generic version of Sanofi's blockbuster drug Lovenox.

The U.S. Food and Drug Administration, which was also named in the suit, approved a generic version of the blood-thinner last Friday. Sanofi's suit is seeking to have the approval rescinded.

In a statement, Momenta said that the court will hold a hearing on Aug. 17 to consider a temporary injunction against the generic product. The company added that the court has not placed any sales restrictions on the product in the meantime.


Breaking Legal News  |  Headline News  |  Law Center  |  Legal Business  |  Court News  |  Law Firm News  |  Legal Interviews |  Political and Legal
Practice Focuses  |  Legal Spotlight  |  Events & Seminars  |  Legal Marketing  |  Court Watch  |  Immigration  |  Press Releases
International  |  Politics  |  Justice Stories  |  Web Design for Law Firms  |  Celebrity Courthouse
Law Promo's specialty is law firm web site design. Law Firm Web Design by Law Promo
© The Legal News Journal. All rights reserved.